Nurix Therapeutics
Healthcare & Life Sci
Company overview
Nurix Therapeutics is a biopharmaceutical company that discovers and develops small molecule therapies based on targeted protein degradation. Its drugs aim to eliminate disease-causing proteins by using the cell's own protein degradation machinery. The company is also developing Degrader-Antibody Conjugates, which combine the targeting ability of antibodies with the potency of its protein degraders.
Nurix has strategic collaboration agreements with Gilead Sciences, Sanofi and Pfizer. Three separate partnerships with major pharmaceutical companies is a sign that larger drugmakers are backing its protein degradation platform. Historically, the median salary is ~$236,683. Nurix Therapeutics is an H-1B sponsor.
- Industry
- Healthcare & Life Sci
- Headquarters
- Brisbane, United States